Home » Topics » BioWorld Science

BioWorld Science
RSS

Canadian approval of Aldurazyme for MPS I

June 11, 2004

Paired biopsy study shows normal bone formation after five years of risedronate

June 11, 2004

Orphan drug designation for Thymosin beta4 for epidermolysis bullosa

June 11, 2004

Novel DPP-IV inhibitor improves glucose tolerance but does not affect diabetes progression

June 11, 2004

Novel PPARgamma activator ameliorates insulin resistance via elevated adiponectin levels

June 11, 2004

Pharmacokinetics of new polyenemacrolide antifungal agent in rats

June 11, 2004

Novel protein-tyrosine-phosphatase 1B inhibitor improves glucose homeostasis in vivo

June 11, 2004

Perifosine reported well tolerated in advanced cancer patients

June 11, 2004

Clinical response achieved with clofarabine in pediatric acute leukemia

June 11, 2004

Update on the pharmacokinetics and effects of ciclesonide in asthma

June 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...